Díaz-Rubio M - Search Results

1

Infliximab treatment and prognostic factors for response in patients with Crohn's disease.

Mendoza JL, García-Paredes J, Cruz Santamaria DM, Lana R, Ramírez Fernández E, Rodríguez Asteaga E, Díaz-Rubio M. Mendoza JL, et al. Rev Esp Enferm Dig. 2002 May;94(5):269-79. Rev Esp Enferm Dig. 2002. PMID: 12474335 English, Spanish.

2

Mycobacterium avium subspecies paratuberculosis and its relationship with Crohn's disease.

Mendoza JL, Lana R, Díaz-Rubio M. Mendoza JL, et al. World J Gastroenterol. 2009 Jan 28;15(4):417-22. doi: 10.3748/wjg.15.417. World J Gastroenterol. 2009. PMID: 19152445 Free PMC article. Review.

3

Need for infliximab dose intensification in Crohn's disease and ulcerative colitis.

Taxonera C, Olivares D, Mendoza JL, Díaz-Rubio M, Rey E. Taxonera C, et al. World J Gastroenterol. 2014 Jul 21;20(27):9170-7. doi: 10.3748/wjg.v20.i27.9170. World J Gastroenterol. 2014. PMID: 25083091 Free PMC article.

4

A continuous spectrum of neutrophilic dermatoses in Crohn's disease.

Mendoza JL, García-Paredes J, Peña AS, Cruz-Santamaría DM, Iglesias C, Díaz Rubio M. Mendoza JL, et al. Rev Esp Enferm Dig. 2003 Mar;95(3):233-6, 229-32. Rev Esp Enferm Dig. 2003. PMID: 12760712 English, Spanish.

5

Prevalence of mutations of the NOD2/CARD15 gene and relation to phenotype in Spanish patients with Crohn disease.

Mendoza JL, Murillo LS, Fernández L, Peña AS, Lana R, Urcelay E, Cruz-Santamaría DM, de la Concha EG, Díaz-Rubio M, García-Paredes J. Mendoza JL, et al. Scand J Gastroenterol. 2003 Dec;38(12):1235-40. doi: 10.1080/00365520310006612. Scand J Gastroenterol. 2003. PMID: 14750643

6

Experience with granulocytapheresis in Crohn's disease.

Cuenca F, García Paredes J, Mendoza JL, Cruz DM, Herrero A, Díaz-Rubio M. Cuenca F, et al. Rev Esp Enferm Dig. 2004 Jul;96(7):501-3, 504-6. doi: 10.4321/s1130-01082004000700007. Rev Esp Enferm Dig. 2004. PMID: 15283632 Free article. English, Spanish.

7

Diagnostic and treatment recommendations on perianal Crohn's disease.

Mendoza JL, Taxonera C, Lana R, Alba C, García-Paredes J, Díaz-Rubio M. Mendoza JL, et al. Rev Esp Enferm Dig. 2005 Jan;97(1):46-56. doi: 10.4321/s1130-01082005000100006. Rev Esp Enferm Dig. 2005. PMID: 15801897 Free article. English, Spanish.

8

Polymorphisms in the interleukin-10 gene and relation to phenotype in patients with ulcerative colitis.

Mendoza JL, Urcelay E, Lana R, Martínez A, Taxonera C, de la Concha EG, Díaz-Rubio M. Mendoza JL, et al. Rev Esp Enferm Dig. 2006 Feb;98(2):93-100. doi: 10.4321/s1130-01082006000200004. Rev Esp Enferm Dig. 2006. PMID: 16566641 Free article. English, Spanish.

9

[Adalimumab induction and maintenance therapy for Crohn's disease. An open-label study].

López Palacios N, Mendoza JL, Taxonera C, Lana R, Fuentes Ferrer M, Díaz-Rubio M. López Palacios N, et al. Rev Esp Enferm Dig. 2008 Nov;100(11):676-81. doi: 10.4321/s1130-01082008001100002. Rev Esp Enferm Dig. 2008. PMID: 19159170 Free article. Clinical Trial. Spanish.

10

IBD1 and IBD3 determine location of Crohn's disease in the Spanish population.

Fernandez L, Mendoza JL, Martinez A, Urcelay E, Fernandez-Arquero M, Garcia-Paredes J, Peña AS, Diaz-Rubio M, de la Concha EG. Fernandez L, et al. Inflamm Bowel Dis. 2004 Nov;10(6):715-22. doi: 10.1097/00054725-200411000-00004. Inflamm Bowel Dis. 2004. PMID: 15626888

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

276 results

Search Page

Filters